This list included several oncogenes, namely MIR544A, MIR146B, FAM83A (also known as tumor antigen BJ‐TSA‐9), the cancer‐germline genes PBK (PDZ binding kinase) and PRAME (preferentially expressed antigen in melanoma), and GCKR that, with PRAME, is a downstream target of the BCR‐ABL protein (Shi et al., 1999; Watari et al., 2000). This evidence concerns the gene ABL1 and cancer.